Conversely, in vivo inhibition of MELK activity through the inhibitor OTSSP167 in breast cancer xenograft models revealed that inhibition of MELK activity reduced the growth of basal-like cell breast cancer xenografts, but not of luminal cell breast cancer xenografts (Wang et al. 2014). This evidence concerns the gene MELK and breast cancer.